Overview

Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The current study is conducted to corroborate the previous observational clinical trial with more valid methods and a more clinically relevant experimental design. This study aims to compare efficacy, safety, and cost between topically administered 30% resin lacquer for the treatment of dermatophyte toenail onychomycosis and the current "best practices": topical 5% amorolfine and systemic terbinafine.
Phase:
Phase 4
Details
Lead Sponsor:
Helsinki University Central Hospital
Collaborator:
Repolar Ltd.
Treatments:
Amorolfine
Terbinafine